T. A. Plumpton

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls

Steven Young‐Min, C. A. Beeton, R Laughton et al. · Annals of the Rheumatic Diseases · 2001 · 84 citations

Medicine, Pathobiology, Pathology +13

A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilagein vitro

H. J. Andrews, T. A. Plumpton, Gregory P. Harper et al. · Inflammation Research · 1992 · 42 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Inhibition of interleukin‐1‐induced collagenase production in human articular chondrocytes in vitro by recombinant human interferon‐gamma

H. J. Andrews, R.A.D. Bunning, T. A. Plumpton et al. · Arthritis & Rheumatism · 1990 · 33 citations

Dentistry, Cell Biology, Immunology +17

Development of an enzyme-linked immunosorbent assay to measure total TIMP-1 (Free TIMP-1 and TIMP-1 in combination with matrix-metalloproteinases) and measurement of TIMP 1 and CRP in serum

T. A. Plumpton, Ian M. Clark, Christopher Plumpton et al. · Clinica Chimica Acta · 1995 · 30 citations

Life Sciences, Biochemistry, Clinical Biochemistry +6

Role of TIMP and MMP Inhibition in Preventing Connective Tissue Breakdown^a

Tim Cawston, T. A. Plumpton, Valerie Curry et al. · Annals of the New York Academy of Sciences · 1994 · 30 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11